Publication: THE EFFECT OF THE JADA DEVICE ON POSTPARTUM HEMORRHAGE IN THE FIRST 24 HOURS
Loading...
Date
2025-04-17
Authors
Journal Title
Journal ISSN
Volume Title
Type
Poster
Abstract
Postpartum hemorrhage (PPH), an extreme loss of blood after birth, is the leading cause of maternal mortality worldwide. 80% of the time, this is due to uterine atony. The uterus is tired after birth and remains completely relaxed. A woman experiencing PPH can bleed out and die in minutes. In the past, controlling a PPH took hours utilizing traditional uterotonic medications and balloon-tamponade devices. Women frequently lost their uterus and were left with lifelong reproductive issues. However, now, we can solve this problem in as little as three minutes with the Jada Device. The Jada device was created in 2011 and FDA approved in 2020. It is a vacuum-tamponade device. It is inserted into the atonic uterus and suctions it, forcing it to clamp down and stopping the hemorrhage. A balloon-tamponade device is simply inflated and puts pressure on the walls of the uterus. The Jada device, however, treats the cause of the hemorrhage (uterine atony) instead of simply masking it, as the balloon device does. Right now, the Jada device is in 2,000 hospitals nationwide. However, there are over 6,000 in the nation total, not to mention the rest of the world. The risk for fatal PPH skyrockets in underdeveloped countries. This device needs to be put into every hospital in every country in the world. The Jada device is the solution for PPH when traditional uterotonics have failed. A balloon tamponade system is 87% effective, while the Jada system boasts 94% efficacy. Other options are surgical intervention, which is risky and likely not available in underdeveloped countries and rural areas. The Jada device can be used anywhere and by almost anyone.